Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy

Podocyte injury plays an important role in diabetic nephropathy (DN), and apoptosis is one of its mechanisms. The transient receptor potential channel 6 (TRPC6) is expressed in podocytes and mediates podocyte injury induced by high glucose levels. Tacrolimus is a novel immunosuppressive agent that i...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruixia Ma, Ying Wang, Yan Xu, Rui Wang, Xianghua Wang, Ning Yu, Minghui Li, Yan Zhou
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2021/8832114
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550251222794240
author Ruixia Ma
Ying Wang
Yan Xu
Rui Wang
Xianghua Wang
Ning Yu
Minghui Li
Yan Zhou
author_facet Ruixia Ma
Ying Wang
Yan Xu
Rui Wang
Xianghua Wang
Ning Yu
Minghui Li
Yan Zhou
author_sort Ruixia Ma
collection DOAJ
description Podocyte injury plays an important role in diabetic nephropathy (DN), and apoptosis is one of its mechanisms. The transient receptor potential channel 6 (TRPC6) is expressed in podocytes and mediates podocyte injury induced by high glucose levels. Tacrolimus is a novel immunosuppressive agent that is reported to play an important role in podocyte protection. The purpose of this study was to investigate the potential mechanism of podocyte protection by tacrolimus in a type 2 diabetic mellitus (T2DM) rat model and in immortalized mouse podocytes (MPC5). Transmission electron microcopy was used to evaluate renal injury morphology. After treatment with FK506, we measured 24-hour urinary albumin-to-creatinine ratios and creatinine clearance rates as well as major biochemical parameters such as glucose, insulin, serum creatinine, urea nitrogen, total cholesterol, triglycerides, alanine transaminase, and aspartate aminotransferase. Nephrin and TRPC6 protein expression and podocyte apoptotic rates in vivo and in vitro were measured using immunohistochemical staining, TUNEL assays, and flow cytometry, respectively. Western blot was used to measure expression of cleaved-caspase-3 and bax/bcl-2. Exposed to high glucose (HG), DM rats exhibited disrupted biochemical conditions and impaired podocyte structure. Decreased expression of nephrin and increased expression of TRPC6, cleaved-caspase-3, and bax/bcl-2 ratios were found in podocytes, along with higher apoptotic percentage, while tacrolimus intervention counteracted the effect of HG on podocytes. Our results suggest that tacrolimus protects podocytes during the progression of type 2 diabetic nephropathy, possibly ameliorating podocyte apoptosis by downregulating the expression of TRPC6.
format Article
id doaj-art-04accbeb2ddf46f4907702ee52defd23
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-04accbeb2ddf46f4907702ee52defd232025-02-03T06:07:16ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/88321148832114Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic NephropathyRuixia Ma0Ying Wang1Yan Xu2Rui Wang3Xianghua Wang4Ning Yu5Minghui Li6Yan Zhou7Department of Nephrology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Nephrology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Nephrology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Intensive Care Unit, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Nephrology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Ultrasound, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Emergency, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Nephrology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaPodocyte injury plays an important role in diabetic nephropathy (DN), and apoptosis is one of its mechanisms. The transient receptor potential channel 6 (TRPC6) is expressed in podocytes and mediates podocyte injury induced by high glucose levels. Tacrolimus is a novel immunosuppressive agent that is reported to play an important role in podocyte protection. The purpose of this study was to investigate the potential mechanism of podocyte protection by tacrolimus in a type 2 diabetic mellitus (T2DM) rat model and in immortalized mouse podocytes (MPC5). Transmission electron microcopy was used to evaluate renal injury morphology. After treatment with FK506, we measured 24-hour urinary albumin-to-creatinine ratios and creatinine clearance rates as well as major biochemical parameters such as glucose, insulin, serum creatinine, urea nitrogen, total cholesterol, triglycerides, alanine transaminase, and aspartate aminotransferase. Nephrin and TRPC6 protein expression and podocyte apoptotic rates in vivo and in vitro were measured using immunohistochemical staining, TUNEL assays, and flow cytometry, respectively. Western blot was used to measure expression of cleaved-caspase-3 and bax/bcl-2. Exposed to high glucose (HG), DM rats exhibited disrupted biochemical conditions and impaired podocyte structure. Decreased expression of nephrin and increased expression of TRPC6, cleaved-caspase-3, and bax/bcl-2 ratios were found in podocytes, along with higher apoptotic percentage, while tacrolimus intervention counteracted the effect of HG on podocytes. Our results suggest that tacrolimus protects podocytes during the progression of type 2 diabetic nephropathy, possibly ameliorating podocyte apoptosis by downregulating the expression of TRPC6.http://dx.doi.org/10.1155/2021/8832114
spellingShingle Ruixia Ma
Ying Wang
Yan Xu
Rui Wang
Xianghua Wang
Ning Yu
Minghui Li
Yan Zhou
Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
Journal of Diabetes Research
title Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
title_full Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
title_fullStr Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
title_full_unstemmed Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
title_short Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
title_sort tacrolimus protects podocytes from apoptosis via downregulation of trpc6 in diabetic nephropathy
url http://dx.doi.org/10.1155/2021/8832114
work_keys_str_mv AT ruixiama tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT yingwang tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT yanxu tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT ruiwang tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT xianghuawang tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT ningyu tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT minghuili tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy
AT yanzhou tacrolimusprotectspodocytesfromapoptosisviadownregulationoftrpc6indiabeticnephropathy